de Morgan Stanley TG Therapeutics TGTX Historial de posiciones en acciones
Compró
Mantenido
Vendió
| Trimestre | Valor de mercado | Estado | Núm. de acciones |
Cambio en la participación | Valor operado | Peso en el portafolio | Posición de la cartera | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | USD 88 M | Comprar |
1,601,714
+193,544
| +14% | +USD 7.92 M | ﹤0.01% | 1681 |
|
|
2026
Q1 | USD 46.8 M | Vender |
1,408,170
-94,867
| -6% | -USD 2.83 M | ﹤0.01% | 2165 |
|
|
2025
Q4 | USD 44.8 M | Comprar |
1,503,037
+255,236
| +20% | +USD 8.34 M | ﹤0.01% | 2188 |
|
|
2025
Q3 | USD 45.1 M | Vender |
1,247,801
-154,812
| -11% | -USD 5.1 M | ﹤0.01% | 2092 |
|
|
2025
Q2 | USD 50.5 M | Vender |
1,402,613
-647,935
| -32% | -USD 24.1 M | ﹤0.01% | 1923 |
|
|
2025
Q1 | USD 80.9 M | Vender |
2,050,548
-113,886
| -5% | -USD 3.83 M | 0.01% | 1405 |
|
|
2024
Q4 | USD 65.1 M | Vender |
2,164,434
-34
| -0% | -USD 976 | ﹤0.01% | 1589 |
|
|
2024
Q3 | USD 50.6 M | Comprar |
2,164,468
+675,726
| +45% | +USD 14.8 M | ﹤0.01% | 1814 |
|
|
2024
Q2 | USD 26.5 M | Comprar |
1,488,742
+317,005
| +27% | +USD 5.06 M | ﹤0.01% | 2369 |
|
|
2024
Q1 | USD 17.8 M | Vender |
1,171,737
-317,746
| -21% | -USD 5.06 M | ﹤0.01% | 2826 |
|
|
2023
Q4 | USD 25.4 M | Vender |
1,489,483
-387,197
| -21% | -USD 4.5 M | ﹤0.01% | 2430 |
|
|
2023
Q3 | USD 15.7 M | Comprar |
1,876,680
+186,498
| +11% | +USD 2.6 M | ﹤0.01% | 2705 |
|
|
2023
Q2 | USD 42 M | Comprar |
1,690,182
+417,406
| +33% | +USD 10.8 M | ﹤0.01% | 1735 |
|
|
2023
Q1 | USD 19.1 M | Comprar |
1,272,776
+498,536
| +64% | +USD 7.57 M | ﹤0.01% | 2483 |
|
|
2022
Q4 | USD 9.16 M | Comprar |
774,240
+397,442
| +105% | +USD 2.88 M | ﹤0.01% | 3172 |
|
|
2022
Q3 | USD 2.23 M | Vender |
376,798
-1,522,212
| -80% | -USD 10 M | ﹤0.01% | 4353 |
|
|
2022
Q2 | USD 8.07 M | Comprar |
1,899,010
+810,658
| +74% | +USD 5.06 M | ﹤0.01% | 3293 |
|
|
2022
Q1 | USD 10.4 M | Comprar |
1,088,352
+522,110
| +92% | +USD 6.04 M | ﹤0.01% | 2870 |
|
|
2021
Q4 | USD 10.8 M | Vender |
566,242
-113,956
| -17% | -USD 2.96 M | ﹤0.01% | 2876 |
|
|
2021
Q3 | USD 22.6 M | Comprar |
680,198
+379,122
| +126% | +USD 11.7 M | ﹤0.01% | 1959 |
|
|
2021
Q2 | USD 11.7 M | Comprar |
301,076
+237,714
| +375% | +USD 9.33 M | ﹤0.01% | 2807 |
|
|
2021
Q1 | USD 3.05 M | Vender |
63,362
-190,548
| -75% | -USD 9.16 M | ﹤0.01% | 3908 |
|
|
2020
Q4 | USD 13.2 M | Comprar |
253,910
+113,779
| +81% | +USD 3.84 M | ﹤0.01% | 2228 |
|
|
2020
Q3 | USD 3.75 M | Vender |
140,131
-22,137
| -14% | -USD 509 k | ﹤0.01% | 3002 |
|
|
2020
Q2 | USD 3.16 M | Vender |
162,268
-151,163
| -48% | -USD 2.43 M | ﹤0.01% | 3129 |
|
|
2020
Q1 | USD 3.08 M | Comprar |
313,431
+1,968
| +0.6% | +USD 24.9 k | ﹤0.01% | 2938 |
|
|
2019
Q4 | USD 3.46 M | Comprar |
311,463
+92,575
| +42% | +USD 704 k | ﹤0.01% | 3585 |
|
|
2019
Q3 | USD 1.23 M | Comprar |
218,888
+108,168
| +98% | +USD 754 k | ﹤0.01% | 4169 |
|
|
2019
Q2 | USD 958 k | Comprar |
110,720
+33,903
| +44% | +USD 256 k | ﹤0.01% | 4247 |
|
|
2019
Q1 | USD 618 k | Vender |
76,817
-577,508
| -88% | -USD 3.12 M | ﹤0.01% | 4433 |
|
|
2018
Q4 | USD 2.68 M | Comprar |
654,325
+476,531
| +268% | +USD 2.37 M | ﹤0.01% | 3525 |
|
|
2018
Q3 | USD 996 k | Vender |
177,794
-69,059
| -28% | -USD 789 k | ﹤0.01% | 4538 |
|
|
2018
Q2 | USD 3.25 M | Comprar |
246,853
+88,737
| +56% | +USD 1.22 M | ﹤0.01% | 3621 |
|
|
2018
Q1 | USD 2.24 M | Vender |
158,116
-21,461
| -12% | -USD 274 k | ﹤0.01% | 3900 |
|
|
2017
Q4 | USD 1.47 M | Comprar |
179,577
+77,089
| +75% | +USD 674 k | ﹤0.01% | 4282 |
|
|
2017
Q3 | USD 1.21 M | Vender |
102,488
-1,915
| -2% | -USD 21.8 k | ﹤0.01% | 4305 |
|
|
2017
Q2 | USD 1.05 M | Vender |
104,403
-57
| -0.1% | -USD 638 | ﹤0.01% | 4341 |
|
|
2017
Q1 | USD 1.22 M | Vender |
104,460
-20,310
| -16% | -USD 146 k | ﹤0.01% | 4230 |
|
|
2016
Q4 | USD 580 k | Comprar |
124,770
+21,397
| +21% | +USD 125 k | ﹤0.01% | 4836 |
|
|
2016
Q3 | USD 801 k | Comprar |
103,373
+52,491
| +103% | +USD 338 k | ﹤0.01% | 4200 |
|
|
2016
Q2 | USD 309 k | Vender |
50,882
-20,703
| -29% | -USD 168 k | ﹤0.01% | 4714 |
|
|
2016
Q1 | USD 610 k | Comprar |
71,585
+25,107
| +54% | +USD 220 k | ﹤0.01% | 4299 |
|
|
2015
Q4 | USD 555 k | Vender |
46,478
-11,447
| -20% | -USD 145 k | ﹤0.01% | 4477 |
|
|
2015
Q3 | USD 583 k | Vender |
57,925
-1,615
| -3% | -USD 24.1 k | ﹤0.01% | 4504 |
|
|
2015
Q2 | USD 988 k | Vender |
59,540
-15,387
| -21% | -USD 244 k | ﹤0.01% | 4206 |
|
|
2015
Q1 | USD 1.16 M | Comprar |
74,927
+4,755
| +7% | +USD 72 k | ﹤0.01% | 4014 |
|
|
2014
Q4 | USD 1.11 M | Comprar |
70,172
+50,372
| +254% | +USD 656 k | ﹤0.01% | 4067 |
|
|
2014
Q3 | USD 212 k | Comprar |
19,800
+936
| +5% | +USD 8.68 k | ﹤0.01% | 5116 |
|
|
2014
Q2 | USD 177 k | Vender |
18,864
-92,574
| -83% | -USD 592 k | ﹤0.01% | 5226 |
|
|
2014
Q1 | USD 769 k | Comprar |
111,438
+109,799
| +6,699% | +USD 650 k | ﹤0.01% | 4223 |
|
|
2013
Q4 | USD 6 k | Comprar |
+1,639
| Nuevas | +USD 6.62 k | ﹤0.01% | 6126 |
|
|
2013
Q3 | – | Vender |
-32,980
| Cerradas | -USD 211 k | – | 5384 |
|
|
2013
Q2 | USD 211 k | Comprar |
+32,980
| Nuevas | +USD 211 k | ﹤0.01% | 4818 |
|
Otros fondos que tienen TGTX en su cartera
Posición de Morgan Stanley en TGTX: resumen de T2 2026
Morgan Stanley aumentó su participación en TG Therapeutics (TGTX) en 14% durante T2 2026, al comprar aproximadamente USD 7.92 M y elevar la posición a 1,601,714 acciones con un valor de USD 88 M. La posición representa ﹤0.01% de la cartera y ocupa el puesto #1681.
Morgan Stanley reportó por primera vez una posición en TGTX en T2 2013 y la ha mantenido durante 52 trimestres desde entonces. Al cierre de T2 2026, 433 fondos que sigue Wall St. Rank mantienen una posición en TGTX.
- Al cierre de T2 2026, Morgan Stanley tenía 1,601,714 acciones de TG Therapeutics con un valor de USD 88 M.
- Morgan Stanley compró 193,544 acciones de TG Therapeutics en T2 2026, por un monto estimado de USD 7.92 M.
- TG Therapeutics representó ﹤0.01% de la cartera de Morgan Stanley en T2 2026 y fue su posición número 1681.
- Morgan Stanley reportó por primera vez una posición en TG Therapeutics en T2 2013 y la ha mantenido durante 52 trimestres desde entonces.
- Al cierre de T2 2026, 433 fondos que sigue Wall St. Rank tenían TG Therapeutics en cartera.
Según el Informe 13F de Morgan Stanley correspondiente a T2 2026, presentado el 13 ago 2026.